Atezolizumab (atezo) therapy for locally advanced/metastatic urinary tract carcinoma (mUTC) in patients (pts) with poor performance status (PS): Analysis of the prospective global SAUL study.

Research output: Contribution to conferencePosterAcademic

Original languageEnglish
Publication statusPublished - 2020
EventASCO 2020 Virtual Annual Meeting -
Duration: 1 Jun 2020 → …


ConferenceASCO 2020 Virtual Annual Meeting
Period1/06/2020 → …

Cite this